Vivani Medical, Inc.

VANI Healthcare Biotechnology

In the quarter to June 2026, EPS grew 41.7% and free cash flow was flat, each against the same quarter a year earlier. Insiders bought in the last twelve months.

1.12 0.03 −2.61%
Market cap
$103.7M
P/E
0.0×
Fwd P/E
−2.6×
Dividend yield
—
F-score
5/9
Altman Z
−26.19
Beneish M
12.36
Dividend safety
n/a
Older periods Sep '25 Dec '25 Mar '26 Jun '26
P/E ratio

+8 more quarters

— — — —
EV/Sales
— — — —
EV/FCF
— — — —
Current Ratio
0.61 2.71 3.18 3.25
Net Debt/EBITDA
0.40 2.42 2.95 2.95
Debt/Equity
0.00 0.00 0.00 0.00
Free Cash Flow Yield
— — — —
Free Cash Flow per Share
(0.12) (0.11) (0.08) (0.07)
Book value per Share
0.02 0.25 0.23 0.22
Free Cash Flow
(7.17) (6.99) (6.20) (6.13)
EV/EBIT
— — — —
Other line items

Show all line items

Columns are period end dates